No retraction, correction or concern found when last checked on Oct 31, 2026.
The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy
Christopher P Webster, Emma F Smith, Claudia S Bauer and 12 more
The EMBO Journal · 2016 · CC BY
Abstract
A GGGGCC hexanucleotide repeat expansion in the C9orf72 gene is the most common genetic cause of amyotrophic lateral sclerosis and frontotemporal dementia (C9ALS/FTD). C9orf72 encodes two C9orf72 protein isoforms of unclear function. Reduced levels of C9orf72 expression have been reported in C9ALS/FTD patients, and although C9orf72 haploinsufficiency has been proposed to contribute to C9ALS/FTD, its significance is not yet clear. Here, we report that C9orf72 interacts with Rab1a and the Unc‐51‐like kinase 1 (ULK1) autophagy initiation complex. As a Rab1a effector, C9orf72 controls initiation of autophagy by regulating the Rab1a‐dependent trafficking of the ULK1 autophagy initiation complex to the phagophore. Accordingly, reduction of C9orf72 expression in cell lines and primary neurons attenuated autophagy and caused accumulation of p62‐positive puncta reminiscent of the p62 pathology observed in C9ALS/FTD patients. Finally, basal levels of autophagy were markedly reduced in C9ALS/FTD patient‐derived iNeurons. Thus, our data identify C9orf72 as a novel Rab1a effector in the regulation of autophagy and indicate that C9orf72 haploinsufficiency and associated reductions in autophagy might be the underlying cause of C9ALS/FTD‐associated p62 pathology. C9ALS/FTD‐associated C9orf72 is a Rab1a effector that controls initiation of autophagy by regulating ULK1 complex trafficking. Disruption of C9orf72 function inhibits autophagy and mimics the p62 pathology found in C9ALS/FTD patients. C9ALS/FTD iNeurons display reduced autophagy. ALS/FTD‐associated C9orf72 is a Rab1a effector that controls initiation of autophagy by regulating ULK1 complex trafficking.
Cited by papers we hold 23
- Regulation of neuronal autophagy and the implications in neurodegenerative diseases · 2022Not checked
- A Review of the Common Neurodegenerative Disorders: Current Therapeutic Approaches and the Potential Role of Nanotherapeutics · 2022No notice
- C9ORF72: What It Is, What It Does, and Why It Matters · 2021No notice
- Autophagy in major human diseases · 2021No notice
- Structural basis for VPS34 kinase activation by Rab1 and Rab5 on membranes · 2021No notice
- Molecular and Cellular Mechanisms Affected in ALS · 2020No notice
- Disrupted neuronal trafficking in amyotrophic lateral sclerosis · 2019No notice
- RNA toxicity in non‐coding repeat expansion disorders · 2019No notice
- Autophagic and endo-lysosomal dysfunction in neurodegenerative disease · 2019No notice
- Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis · 2019Corrected
- Micro-RNAs secreted through astrocyte-derived extracellular vesicles cause neuronal network degeneration in C9orf72 ALS · 2019No notice
- A molecular perspective of mammalian autophagosome biogenesis · 2018No notice
- A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy · 2018No notice
- Autophagy: An Essential Degradation Program for Cellular Homeostasis and Life · 2018No notice
- The Enigmatic Role of C9ORF72 in Autophagy · 2017Not checked
- Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities? · 2017Not checked
- Modelling amyotrophic lateral sclerosis: progress and possibilities · 2017No notice
- Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand · 2017No notice
- SRSF1-dependent nuclear export inhibition of C9ORF72 repeat transcripts prevents neurodegeneration and associated motor deficits · 2017No notice
- The mammalian ULK1 complex and autophagy initiation · 2017No notice
and 3 more
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.